CTC Clinical Trial Consultants AB was founded 2011 and is 100% privately owned by employees. Building on a solid foundation of experience and competence in running early clinical trials, key staff members from the former Berzelius Clinical Research Center AB and Quintiles AB have founded a private company, CTC Clinical Trial Consultants AB (CTC), to support customers with hospital-based early phase (0 / I / IIa) clinical trials. CTC has a 12-bed, state-of-the-art, fully equipped clinical research unit at Akademiska University Hospital in Uppsala. The location of the unit is “next-door” (20 meters further down the hallway) to the central intensive care unit and to the neuro intensive care unit.
The unit was inspected by the Medical Products Agency in Sweden 2015 and received an approval for performing FIM trials.
CTC also collaborates closely with other CROs and/or Sponsors for supplementary services. Professor Folke Sjöberg/ Assoc. Professor Fredrik Huss / MD Cornelia Tiberg, will serve as principal investigators supported by a team of experienced physicians, research nurses and site managers. As principal investigators Professor Folke Sjöberg / Assoc. Professor Fredrik Huss, and MD Cornelia Tiberg have, together with the key staff, successfully conducted over 150 industry sponsored clinical trials. A significant number (15) of those have been First-In-Man (FIM) studies including high-risk compounds.
Flexibility and responsiveness to customer requirements are easier to implement in a smaller organization. We, in collaboration with other specialists in our network, can offer the same resources and capabilities as substantially larger companies. Besides conventional phase I and IIa studies, one of our specialties in translational/exploratory medicine is methods (e.g. microdosing/microdialysis techniques) to get early indications of pharmacological activity in humans (healthy volunteers and/or patients).